Related Experiment Video
Updated: Jul 11, 2026

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
Published on: April 11, 2012
Steroid use in sepsis-induced conjugated hyperbilirubinemia: report of one case
Jinn-Li Wang1, Tsong-Yih Ou, Chun-Nan Chen
1Department of Pediatrics, Taipei Medical University-Wan Fang Medical Center, Taiwan. jlwang@wanfang.gov.tw
Insights
Steroids may treat severe conjugated hyperbilirubinemia in children with gram-negative sepsis. This approach rapidly improved a leukemia patient with Escherichia coli sepsis and jaundice.
Area of Science:
- Pediatric Hematology Oncology
- Neonatal and Pediatric Sepsis Management
- Hepatology and Liver Disease
Background:
- Acute lymphoblastic leukemia (ALL) is a common childhood cancer.
- Gram-negative bacterial sepsis can lead to severe complications, including liver dysfunction.
- Conjugated hyperbilirubinemia is a serious condition characterized by elevated direct bilirubin levels.
Observation:
- A pediatric patient with ALL developed severe conjugated hyperbilirubinemia following Escherichia coli sepsis.
- The patient's jaundice worsened despite broad-spectrum antibiotic treatment.
- Neurological status declined, prompting the initiation of steroid therapy.
Findings:
- Hydrocortisone therapy at 8 mg/kg/d was administered to the patient.
- Rapid clinical improvement and resolution of hyperbilirubinemia were observed after steroid administration.
- This suggests a potential therapeutic role for steroids in managing this specific complication.
Implications:
- Steroid therapy may be a viable treatment option for progressive conjugated hyperbilirubinemia secondary to gram-negative sepsis in pediatric patients.
- Further research is warranted to confirm the efficacy and safety of steroids in this context.
- This finding could inform clinical guidelines for managing complex cases of sepsis-induced liver injury in children.
Abstract:
We report a girl with acute lymphoblastic leukemia who developed severe conjugated hyperbilirubinemia (total bilirubin 34.32 mg/dl, direct bilirubin 26.94 mg/dl) following gram-negative (Escherichia coli ) sepsis. Despite broad-spectrum antibiotics, her hyperbilirubinemia progressed. Her mental status deteriorated and steroid therapy (hydrocortisone 8 mg/kg/d) was initiated. Her condition then recovered rapidly. Based on our findings, we suggest that steroid may help to treat progressive conjugated hyperbilirubinemia due to gram-negative sepsis.
More Related Videos
Related Concept Videos
Jaundice
Cholecystitis
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nephrotic Syndrome II : Assessment and Medical Management
Cirrhosis II: Pathophysiology
